Drug Type Bacteriophage therapy |
Synonyms MP-102, MP102 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pseudomonas aeruginosa infection | Preclinical | South Korea | 01 Nov 2025 | |
| respiratory tract; infection, chronic | Preclinical | South Korea | 01 Nov 2025 |





